EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma creatine, estimated intramuscular creatine, transcellular gradient and the risk of mortality: Results from the PREVEND study

Caecilia S E Doorenbos iD, Adrian Post iD, Mariken E Stegmann, Casper F M Franssen, Robin P F Dullaart iD, Gerjan Navis, Margery A Connelly, Stephan J L Bakker

European Journal of Clinical Investigation · 2026

DOI: 10.1111/eci.70110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2026. Verfasst von Caecilia S E Doorenbos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Creatine, Muscle, Skeletal, Mortality. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nierstichting, Hartstichting, Ausam.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Creatine, an endogenous compound essential for energy metabolism and cellular function, has been associated with numerous beneficial effects in sports and overall health. Here, we investigated relationships between plasma creatine concentration, estimated intramuscular creatine concentration, and all‐cause mortality in the general population.

Methods

In a Dutch prospective population‐based cohort, plasma creatine concentration, 24‐h urinary creatinine excretion and muscle mass (assessed with bio‐electrical impedance analysis) were measured in 5127 participants. Total creatine pool size, calculated from 24‐h creatinine excretion (assuming a 1.7% daily excretion of the total creatine pool), was divided by muscle mass to estimate intramuscular creatine concentrations. Transcellular gradient was calculated as intramuscular concentration divided by plasma concentration. Hazard ratios for mortality per doubling were assessed using multivariable Cox proportional hazard models, adjusting for common cardiovascular risk factors for mortality.

Results

Median plasma creatine concentrations were 41 [30–54] μmol/L in females and 28 [21–38] μmol/L in males. Mean intramuscular creatine concentrations were 30 ± 5.0 mmol/kg in females and 27.4 ± 5.0 mmol/kg in males. Median transcellular creatine gradients were 734 [550–1011] in females and 955 [715–1324] in males. Higher intramuscular creatine concentrations were associated with lower mortality in females (HR (95% CI) = .43 (.2; .66)); with a weaker trend in males (HR (95% CI) = .73 (.53; 1.02)). Plasma creatine concentrations were not associated with mortality.

Conclusion

Higher estimated intramuscular creatine concentrations are strongly associated with lower all‐cause mortality in females, with a weaker trend in males. Future research should explore causality, as well as further explore the remarkable sex difference.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CreatineMuscle, SkeletalMortalityHumansMaleFemaleMiddle AgedProspective StudiesCreatinineAgedProportional Hazards ModelsNetherlandsAdultSex FactorsRisk Factors

Stichwörter der Autor:innen

creatinegeneral populationmortality riskmuscle mass

Substanzen

CreatineCreatinine

Autor:innen und Institutionen

  • Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Primary and Long-Term Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Labcorp, Morrisville, North Carolina, USA.

ORCID-Profile: Caecilia S E Doorenbos, Adrian Post, Robin P F Dullaart

Förderung

  • Nierstichting
  • Hartstichting
  • Ausam
  • Roche
  • Dade Behring
  • Abbott Laboratories

Zitieren

APA

Doorenbos, C. S. E., Post, A., Stegmann, M. E., Franssen, C. F. M., Dullaart, R. P. F., Navis, G., Connelly, M. A., & Bakker, S. J. L. (2026). Plasma creatine, estimated intramuscular creatine, transcellular gradient and the risk of mortality: Results from the PREVEND study. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70110

Vancouver

Doorenbos CSE, Post A, Stegmann ME, Franssen CFM, Dullaart RPF, Navis G, et al. Plasma creatine, estimated intramuscular creatine, transcellular gradient and the risk of mortality: Results from the PREVEND study. European Journal of Clinical Investigation. 2026. doi:10.1111/eci.70110

BibTeX
@article{Doorenbos2026,
  author = {Doorenbos, Caecilia S E and Post, Adrian and Stegmann, Mariken E and Franssen, Casper F M and Dullaart, Robin P F and Navis, Gerjan and Connelly, Margery A and Bakker, Stephan J L},
  title = {Plasma creatine, estimated intramuscular creatine, transcellular gradient and the risk of mortality: Results from the PREVEND study},
  journal = {European Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1111/eci.70110}
}
Kostenlos starten →